WIL Group Connects Global Markets Through API Trading and CDMO Excellence
Exhibitor: WENDY INTERNATIONAL LTD
Date: 2026-03-31
Booth No.: L118
TAICHUNG, TAIWAN – In the rapidly evolving global biopharmaceutical landscape, Taichung-based WIL Group (Wendy International Co., Ltd.) is steadily expanding its footprint across Asia’s biotech raw materials and manufacturing sectors. From active pharmaceutical ingredients (APIs) to health supplements, and from raw material sourcing to integrated contract manufacturing, WIL Group is crafting a comprehensive industry map encompassing R&D, production, regulatory compliance, and distribution.
Bridging the Asian Biotech Blueprint
Wendy Lu, founder of WIL Group, emphasizes that the strategic choice to establish roots in Singapore while maintaining a strong presence in Taiwan allows the group to leverage Singapore’s resource integration and Taiwan’s manufacturing prowess. "We aim to be the 'Bridge of the Asian Raw Material Supply Chain,'" says Lu. "We believe quality and integrity are the bedrock of longevity. Helping our clients succeed is our ultimate responsibility."
Stringent Quality Control: Ensuring Safety at the Source
WIL Group specializes in providing Active Pharmaceutical Ingredients (APIs) and Excipients that meet the rigorous standards of pharmaceutical manufacturers. To address the rising demand for natural health products, the company has expanded into natural essential oils, botanical extracts, and functional health food ingredients.
The group meticulously selects global partners with GMP, FDA, and ISO certifications. Combined with multi-layered laboratory testing and regulatory audits, WIL Group ensures every batch complies with international standards, upholding its core value of "Quality First, Integrity Always."
Integrated CDMO Services: Bridging R&D and Marketization
Beyond supply, WIL Group actively develops its CMO and CDMO (Contract Development and Manufacturing Organization) capabilities. By providing integrated solutions—from formulation R&D and product design to packaging and regulatory filing—WIL Group helps clients meet market demands for efficiency and quality.
For startups and SMEs, these services are vital. Leveraging a professional team with pharmacist backgrounds, WIL Group assists clients in shortening the "Lab-to-Market" cycle, simplifying complex processes to enhance market competitiveness.
Dual-Hub Strategy: Taiwan Roots, Singapore Reach
To deepen its service capacity in the Asia-Pacific, WIL Group recently established Wendy Pharma Pte. Ltd. in Singapore. Functioning as a regional outpost and international logistics hub, the Singapore office enhances supply efficiency and strengthens ties with local pharmaceutical plants, health brands, and OEM manufacturers. This realizes the group’s "Dual-Hub Strategy": Taiwan as the R&D foundation and Singapore as the international gateway.
Diverse Product Portfolio: Meeting Modern Health Trends
WIL Group offers a professional supply system across several core domains:
APIs: High-quality ingredients for cardiovascular, metabolic, and psychiatric medications.
Excipients: High-purity binders, disintegrants, and emulsifiers for dosage stability.
Fine Chemicals & Impurities: Providing reference standards and high-purity chemicals for precise quality control and regulatory filing.
Finished Products: OEM/ODM services for tablets, capsules, and oral liquids.
Botanicals & Supplements: Pesticide-free plant extracts and functional ingredients targeting gut health, sleep management, and anti-oxidation.
Featured Product Highlights
AMPS (Acrylamido Methyl Propane Sulfonic Acid): A versatile rheology modifier/gelling agent for personal care. It remains stable in >70% alcohol formulas (where Carbomers often fail) and provides a silky, non-sticky skin feel.
Effervescent Tablets: Fully customizable OEM services for flavor and ingredients, including the best-selling Vitamin D3+Zinc+C formula.
Party Pal: A sugar-free orodispersible granule using ORAMELT™ technology. It features C3 CURA™ to significantly enhance the bioavailability of Curcuminoids for rapid recovery.
Low-Molecular Apple Oligosaccharide: A plant-based, additive-free supplement refined via three patented thermal processes to ensure high absorption of apple polyphenols and pectin.
For more information, please visit: www.WIL.com.tw
Email: sales@wil.com.tw
Tel: +886-4-26880838
More Exhibitor's Press Release
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08
- Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology and Expands Strategic LONZA / 2026-07-08